The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma
{{output}}
The BCL-2 protein family members inhibit cellular apoptosis, and their overexpression represents a common survival adaption in cancer. Recently, a selective BCL-2 inhibitor ABT-199, venetoclax, has demonstrated remarkable activity in relapsed/refractory chroni... ...
